Loading...
XKRX
000105
Market cap5.37bUSD
Apr 02, Last price  
98,200.00KRW
1D
-1.60%
1Q
-7.45%
Jan 2017
322.15%
Name

Yuhan Corp

Chart & Performance

D1W1MN
P/E
77.53
P/S
3.90
EPS
1,266.55
Div Yield, %
—
Shrs. gr., 5y
2.64%
Rev. gr., 5y
4.12%
Revenues
1.86t
+4.68%
493,285,310,000611,185,646,000646,772,504,000663,570,311,000679,230,981,630776,457,613,410943,609,130,8001,017,491,786,4201,128,731,291,6501,320,797,335,2901,462,248,030,1401,518,822,858,4301,480,353,606,9401,619,865,302,6801,687,810,317,7401,775,846,942,7401,858,983,759,650
Net income
93.51b
-1.72%
92,073,194,000125,644,189,000121,737,854,000128,001,500,00094,217,471,13080,775,749,00086,461,208,09090,947,777,980126,046,994,760161,248,743,740109,034,185,95057,480,741,11040,006,186,810192,761,176,870102,582,679,18095,144,301,42093,509,563,680
CFO
144.13b
+44.81%
97,847,667,000123,117,050,000134,380,244,000149,592,249,00072,377,880,73072,379,345,17079,777,958,88094,385,653,450126,234,690,91074,144,086,540126,125,107,52093,451,633,13065,985,413,05028,830,248,88099,000,468,38099,528,971,400144,128,102,312
Dividend
Dec 27, 2023460 KRW/sh
Earnings
Apr 28, 2025

Profile

Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury; ETC products in the areas of cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems; anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. It also offers OTC products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. In addition, the company engages in dental business and offers implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and household pets. Further, it provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.
URL
https://www.yuhan.co.kr/
IPO date
Nov 01, 1962
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,858,983,760
4.68%
1,775,846,943
5.22%
Cost of revenue
1,604,933,638
1,565,143,942
Unusual Expense (Income)
NOPBT
254,050,122
210,703,001
NOPBT Margin
13.67%
11.86%
Operating Taxes
4,708,853
4,333,847
Tax Rate
1.85%
2.06%
NOPAT
249,341,269
206,369,154
Net income
93,509,564
-1.72%
95,144,301
-7.25%
Dividends
(27,268,933)
(26,079,622)
Dividend yield
0.50%
0.64%
Proceeds from repurchase of equity
(7,457,004)
(16,521,185)
BB yield
0.14%
0.40%
Debt
Debt current
299,864
91,966,049
Long-term debt
634,634
7,661,539
Deferred revenue
400,000
Other long-term liabilities
128,978,124
(62,467,892)
Net debt
(939,539,381)
(815,343,670)
Cash flow
Cash from operating activities
144,128,102
99,528,971
CAPEX
(161,479,680)
(94,378,310)
Cash from investing activities
(187,075,209)
15,621,385
Cash from financing activities
51,092,658
(65,541,959)
FCF
299,506,301
131,024,232
Balance
Cash
322,003,511
347,718,179
Long term investments
618,470,368
567,253,079
Excess cash
847,524,691
826,178,911
Stockholders' equity
2,154,226,373
3,782,398,430
Invested Capital
1,606,976,466
1,188,312,448
ROIC
17.84%
17.71%
ROCE
12.43%
10.01%
EV
Common stock shares outstanding
78,714
75,185
Price
68,800.00
26.29%
54,476.19
-12.28%
Market cap
5,415,507,582
32.22%
4,095,773,878
-12.75%
EV
4,475,968,201
3,303,586,931
EBITDA
298,733,188
253,721,514
EV/EBITDA
14.98
13.02
Interest
2,455,080
3,468,047
Interest/NOPBT
0.97%
1.65%